AzTrials
AzTrials

HalitosisPhase 4NCT02113137

Oral Hygiene Procedures on Reduction of Oral Malodor

A Phase 4 study testing group 1: drug: chlorine dioxide and group 2: device: small tooth brush for tongue cleaning in people with Halitosis, run by Ei Ei Aung at 1 site in Japan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to evaluate the effect of various oral hygiene procedures on reduction of oral malodor. Read more about this study

Who is it for?
Ages 18 to 30 years, men onlyHealthy volunteers can take part
Conditions the study is for
Halitosis
What is being tested?
group 1: drug: chlorine dioxide and group 2: device: small tooth brush for tongue cleaning
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteJapan
Study dates
Sep 2013to Nov 2013
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Clinical diagnosis of oral malodor
  • At least 20 functional teeth
  • No systemic diseases
  • No severe dental diseases

Who cannot join

  • Habit of smoking and betel quid chewing
  • Oral malodor by food and other craniofacial abnormalities
  • Current use of any kind of mouthwash

Trial locations and contacts

1 site in 1 country.

Japan1 site
  • Department of oral health promotion

    Tokyo, Tokyo, 113-8549

Other trials in Japan

About this study

Official title: Effects of Various Oral Hygiene Procedures on the Reduction of Oral Malodor in Periodontally Healthy Patients

The purpose of the study is to evaluate the effect of various oral hygiene procedures on reduction of oral malodor.

Read the detailed description

Thirty volunteers who matched with including criteria were divided randomly into two groups. Both groups were instructed to brush their teeth with a scrubbing method for the first one week. Then, each group received the different additional oral malodor reduction regimen- in addition to tooth brushing tongue cleaning in one group and chlorine dioxide (ClO2) mouthwash in another group for three consecutive weeks. After that, all the participants were instructed to practice all the three oral hygiene procedures (tooth brushing, mouth washing, tongue cleaning) the last one week. Total volatile sulfur compounds (VSCs) measured by breathtron, tongue coating, plaque score and bleeding on probing (BOP) were outcomes of this study.

Conditions
Halitosis
Being tested
group 1: drug: chlorine dioxide, group 2: device: small tooth brush for tongue cleaning
Keywords
halitosis, chlorine dioxide, tongue cleaning
Medical subject headings
Halitosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • group 1: drug: chlorine dioxideDrug

    Also called ClO2Fresh®

    First, each group practiced tooth brushing only for one week. After that each group was requested to do the following procedures.

    group 1 - additional use of 12ml chlorine dioxide (ClO2) mouthwash two times per day, for three consecutive weeks besides tooth brushing.

    At last, each group practiced all three methods of tooth brushing, tongue cleaning, mouth washing.

  • group 2: device: small tooth brush for tongue cleaningDevice

    First, each group practiced tooth brushing only for one week. After that each group was requested to do the following procedures.

    group 2 - additional practice of tongue cleaning by a small tooth brush two times per day, for three consecutive weeks besides tooth brushing.

    At last, each group practiced all three methods of tooth brushing, tongue cleaning, mouth washing.

Study groups in NCT02113137
Study groupRoleWhat they receive
group 1: drugExperimentalDrug: group 1: drug: chlorine dioxide 12ml chlorine dioxide (ClO2) mouthwash two times per day, for three consecutive weeks
Receives: Drug: group 1: drug: chlorine dioxide
group 2: device:Experimentalgroup 2: device: small tooth brush for tongue cleaning small tooth brush for tongue cleaning
Receives: Device: group 2: device: small tooth brush for tongue cleaning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volatile sulfur compounds (VSCs)

    Total volatile sulfur compounds was measured by Breathron®

    Measured: 5 weeks

Secondary outcomes (3)
  1. Bleeding on probing

    gingival bleeding was recorded of bleeding was detected after examination with periodontal probe.

    Measured: 5 weeks

  2. Tongue coating

    tongue coating was evaluated by Winkel tongue coating index.

    Measured: 5weeks

  3. Debris index

    debris index was evaluated by oral hygiene index.

    Measured: 5 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Apr 2014 (estimated)
  2. Study startSep 2013
  3. Primary completionOct 2013
  4. Study completionNov 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02113137
Sponsor's protocol ID
OHP-018-EI
Status last verified
Apr 2014
First submitted
7 Apr 2014
Last updated
14 Apr 2014
Results posted
No
Data monitoring committee
Yes

Publications

  • Aung EE, Ueno M, Zaitsu T, Furukawa S, Kawaguchi Y. Effectiveness of three oral hygiene regimens on oral malodor reduction: a randomized clinical trial. Trials. 2015 Jan 27;16:31. doi: 10.1186/s13063-015-0549-9.

    PubMed 25622725

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing group 1: drug: chlorine dioxide and group 2: device: small tooth brush for tongue cleaning in people with Halitosis, run by Ei Ei Aung at 1 site in Japan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Japan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volatile sulfur compounds (VSCs) (time frame: 5 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02113137, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2014.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in